Sort
326,823 grants matching “clinical trial”
Alzheimer Disease Research Center
$2,260,643Helena Chang Chui · University Of Southern California · P50 · FY2016 · AG
UCSF Specialized Programs of Research Excellence (SPOREs) in Prostate Cancer
$2,260,376Eric J Small · University Of California, San Francisco · P50 · FY2025 · CA
Head and Neck Cancer SPORE
$2,260,252Robert L Ferris · University Of Pittsburgh At Pittsburgh · P50 · FY2016 · CA
VTEU: Phase I Malaria Vaccine Trial
$2,260,233Lisa Jackson · Kaiser Foundation Health Plan Of Washington · N01 · FY2016 · AI
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
$2,259,773Kevin J Cullen · University Of Maryland Baltimore · P30 · FY2016 · CA
MD Anderson Cancer Center Prostate Cancer SPORE
$2,259,759Christopher J. Logothetis · University Of Tx Md Anderson Can Ctr · P50 · FY2016 · CA
UCLA SPORE IN PROSTATE CANCER
$2,259,694Jean B De Kernion · University Of California Los Angeles · P50 · FY2006 · CA
Alzheimer's Disease Research Center at Columbia University
$2,259,502Scott A Small · Columbia University Health Sciences · P50 · FY2013 · AG
SWITCH Trial: Early Feasibility Study of Stentrode BCI for Augmentative Communication
$2,259,253Douglas J Weber · Carnegie-Mellon University · UH3 · FY2022 · NS
NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Required)
$2,258,707William J Irvin · Southeast Clinical Oncol Res Consortium · UG1 · FY2023 · CA
Georgetown University Lombardi Cancer Center Support Grant
$2,258,441Louis M Weiner · Georgetown University · P30 · FY2017 · CA
Studies of Childhood Solid Tumors
$2,258,434Linda M Hendershot · St. Jude Children'S Research Hospital · P01 · FY2009 · CA
Breast Cancer Family Registry Cohort
$2,258,395Esther M John · Cancer Prevention Instit Of California · UM1 · FY2013 · CA
High-dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) CCC
$2,258,351Yvonne W Wu · University Of California, San Francisco · U01 · FY2018 · NS
Alzheimer Disease Research Center
$2,258,230Helena Chang Chui · University Of Southern California · P50 · FY2017 · AG
Preclinical Evaluation of Advanced Pan-Lassa Immunotherapeutic Cocktails
$2,258,151Robert F Garry · La Jolla Institute For Immunology · U19 · FY2020 · AI
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
$2,258,000Mayo Clinic Rochester · N01 · FY2008 · CA
Utilizing continuous ketone monitors to enable safe use of SGLT inhibitors in patients with Type 1 Diabetes
$2,257,919Jeremy H Pettus · University Of California, San Diego · U01 · FY2025 · DK
Cancer as a Complex Adaptive System
$2,257,782Robert A Gatenby · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2016 · CA
PHASE 1 AND PHASE 2 CLINICAL TRIALS OF CANCER CHEMOPREVENTIVE AGENTS
$2,257,713Paul J Limburg · · N01 · FY2007 · CA
MSK SPORE in Genomic Instability in Breast Cancer
$2,257,697Simon N Powell · Sloan-Kettering Inst Can Research · P50 · FY2020 · CA
The MobileToolbox for Monitoring Cognitive Function
$2,257,621Richard Gershon · Northwestern University At Chicago · U2C · FY2021 · AG
Medical Oncology Service Clinical Core
$2,257,611James L. Gulley · Division Of Basic Sciences - Nci · ZID · FY2021 · CA
Carle Cancer Center NCI Community Oncology Research Program (NCORP)
$2,257,582Kendrith Martin Rowland · Carle Foundation · UG1 · FY2024 · CA
Arterial Stiffness, Cognition, and Equol (ACE)
$2,257,337Akira Sekikawa · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AG